Intranasal administration of physostigmine and arecoline

Details Intranasal administration of physostigmine and arecoline Intranasal administration of physostigmine and arecoline

A - Human Necessities

61

K

167/229

A61K 31/455 (2006.01) A61K 9/00 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01)

Patent

CA 2012192

-1- TITLE INTRANASAL ADMINISTRATION OF PHYSOSTIGMINE AND ARECOLINE Abstract of the Disclosure The intranasal administration of arecoline and physostigmine is provided for the treatment of a cognitive deficiency. Such administration of physostigmine is also used to treat overdoses of anticholinergic drugs or to protect a mammal against organophosphate poisoning. Intranasal delivery of these drugs offers a convenient dosage form with efficient bioavailability.

Affiliated with

Also associated with

Rating

Intranasal administration of physostigmine and arecoline does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasal administration of physostigmine and arecoline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal administration of physostigmine and arecoline will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1874955